Lennar (NYSE:LEN) Upgrade of Rating
Lennar (NYSE:LEN)’s stock was increased to Overweight by investment analysts at Barclays, who have a PT of $72.0 on LEN. The firm’s Equal Weight rating is no longer valid.
In spite of the firm’s rating upgrade NYSE:LEN is at the moment trading -0.91% lower at $63.24 as of 4:04 PM New York time. Lennar’s stock is 0% over the last 200 days. It has underperformed the S&P 500, which has gained 6.00% over the same time period.
Element Capital Management Llc had the biggest stake with ownership of 1.08M shares as of q2 2015 for 7.69% of the fund’s portfolio. Oakmont Corp is another quite bullish active investment manager who is owning 1.11 million shares of Lennar or 7.47% of their fund’s portfolio. In addition, Long Pond Capital Lp have 5.44% of their fund’s portfolio invested in the company for 2.75 million shares. The Massachusetts-based fund Covalent Partners Llc disclosed it had acquired a stake worth about 4.81% of the active investment manager’s stock portfolio in Lennar. The New York-based fund Greenhaven Associates Inc is also positive about the stock, possessing 291,621 shares or 4.09% of their fund’s portfolio.
Lennar (NYSE:LEN) Profile
Lennar Corporation is a provider of real estate related financial services, commercial real estate, investment management and finance company. The Company is a homebuilder that operates in various states. Its segments include Homebuilding East, Homebuilding Central, Homebuilding West, Lennar Financial Services, Rialto and Lennar Multifamily.
Lennar (NYSE:LEN) traded down -0.91% on 7 February, hitting $63.24. A total of 2.13 million shares of the company’s stock traded hands. This is down from average of 3.21 million shares. Lennar has a 52 week low of $41.54 and a 52 week high of $64.42. The company has a market cap of $14.84 billion and a P/E ratio of 18.21.
Get the latest Lennar (NYSE:LEN) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
The post Lennar (NYSE:LEN) Increased to Overweight Rating With $72.0 Target Price at Barclays from Equal Weight Rating appeared first on Octafinance.